NSCLC, STAGE III
Clinical trials for NSCLC, STAGE III explained in plain language.
Never miss a new study
Get alerted when new NSCLC, STAGE III trials appear
Sign up with your email to follow new studies for NSCLC, STAGE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for frail lung cancer patients: targeted drug repotrectinib under study
Disease control Recruiting nowThis study tests a drug called repotrectinib in 30 frail or elderly patients with advanced lung cancer that has a specific genetic change (ROS1). The goal is to see if the drug can shrink tumors or stop them from growing. Participants take the drug by mouth, and doctors monitor t…
Matched conditions: NSCLC, STAGE III
Phase: PHASE2 • Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a tailored drug cocktail beat lung cancer recurrence?
Disease control Recruiting nowThis phase 3 trial is testing whether adding an extra immunotherapy drug (tremelimumab) and more chemotherapy to the standard treatment (durvalumab) can lower the amount of cancer DNA found in the blood of people with stage III non-small cell lung cancer. The study enrolls 48 par…
Matched conditions: NSCLC, STAGE III
Phase: PHASE3 • Sponsor: Maximilian Diehn • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New combo therapy aims to shrink lung tumors before surgery
Disease control Recruiting nowThis study tests whether giving a mix of two immunotherapy drugs (sintilimab and IBI310) plus chemotherapy before surgery can shrink tumors in people with stage II-III non-small cell lung cancer. About 54 participants will receive the treatment and then have surgery. The main goa…
Matched conditions: NSCLC, STAGE III
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Could a prostate cancer drug help fight lung cancer?
Disease control Recruiting nowThis study tests whether adding a hormone therapy (leuprorelin) to an immunotherapy (sintilimab) can help older men with advanced lung cancer. The idea is that lowering sex hormones may rejuvenate the immune system, making the immunotherapy more effective. Eighty men aged 60 and …
Matched conditions: NSCLC, STAGE III
Phase: NA • Sponsor: Jinzhou Medical University • Aim: Disease control
Last updated Jun 26, 2026 14:29 UTC
-
Can a tailored home exercise program help lung cancer patients? new study aims to find out
Symptom relief Recruiting nowThis pilot study is testing whether a personalized exercise regimen, delivered via telehealth, is feasible and safe for people with stage II or III non-small cell lung cancer who are receiving chemotherapy or immunotherapy and surgery. Twenty participants will follow a home-based…
Matched conditions: NSCLC, STAGE III
Phase: NA • Sponsor: University of Utah • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC